SCHEMBL7305749

SCHEMBL7305749

COc1ccc(S(=O)(=O)C(C(=O)NOC(C)(C)C)C(C)C)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 10/20 0.71
MMP1 P03956 9/20 0.71
MMP9 P14780 10/20 0.47
ADAM17 P78536 3/20 0.47
MMP2 P08253 8/20 0.45
MMP3 P08254 7/20 0.45
MMP8 P22894 4/20 0.44
MMP12 P39900 2/20 0.44
MMP14 P50281 2/20 0.44
MMP16 P51512 2/20 0.44
MMP7 P09237 1/20 0.43
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
SLC1A3 P43003 1/20 0.41
SLC1A2 P43004 1/20 0.41
SLC1A1 P43005 1/20 0.41
PDE4A P27815 3/20 0.41
PDE4B Q07343 3/20 0.41
PDE4C Q08493 3/20 0.41
PDE4D Q08499 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6928607 0.83 MMP1 (1.00) MMP13MMP1MMP9ADAM17MMP2
SCHEMBL7301899 0.80 MMP1 (0.49) MMP13MMP1MMP9ADAM17MMP2
SCHEMBL6929276 0.78 MMP1 (0.70) MMP13MMP1MMP9ADAM17MMP2
SCHEMBL7344510 0.75 SLC1A3 (0.56) MMP13MMP1MMP9ADAM17MMP2
SCHEMBL7344506 0.75 SLC1A3 (0.56) MMP13MMP1MMP9ADAM17MMP2
SCHEMBL7309436 0.74 MMP1 (0.50) MMP13MMP1MMP9ADAM17MMP2
SCHEMBL6932324 0.73 MMP1 (0.63) MMP13MMP1MMP9ADAM17MMP2
SCHEMBL7312224 0.73 ADAM17 (0.48) MMP13MMP1ADAM17MMP2MMP3
SCHEMBL14636309 0.72 SLC1A3 (0.41) MMP13MMP1MMP9ADAM17MMP2
SCHEMBL6934594 0.71 MMP1 (0.73) MMP13MMP1MMP9ADAM17MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0780386-B1 Matrix metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2002-10-02 EP disclosed
US-5932595-A ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT SYNTEX (U.S.A.) INC. (US) 1999-08-03 US disclosed
EP-0780386-A1 Matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1997-06-25 EP disclosed